Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
Clinical trial NCT03478514 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03478514
- Sponsor
- Alliance Foundation Trials, LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2025-12-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.